Wieslab AB and PKxpert AB sign collaboration agreement within CRO services

November 5, 2015 - Företagsnyheter, Produktnyheter
Wieslab AB and PKxpert AB have signed a collaboration agreement that signifies that the two companies will work jointly on specific projects.

Wieslab AB and PKxpert AB have complementary competences within GLP Bioanalytical and Pharmacokinetics services that will give clients easy access to a more complete range of services for their drug development needs. PKxpert AB’s CEO Annsofi Nihlén states: “I believe Wieslab is an excellent partner for PKxpert to extend our services in drug development. We are excited and looking forward to the cooperation”.

PKxpert AB provides consultancy services and expert knowledge in:

  • Pharmacokinetics (PK) and Toxicokinetics analysis using Phoenix WinNonlin® for non-clinical and clinical data evaluation of
  • Toxicokinetic analysis according to GLP
  • Pharmacokinetic and pharmacodynamic (PKPD) modelling, simulations and predictions
  • Drug metabolism
  • Regulatory ADME (absorption, distribution, metabolism, and excretion) studies
  • Non-clinical research & development project management

Wielsab AB provides GCP and GLP compliant bioanalytical services for non-clinical as well as clinical studies for pharma, biotech, and CRO customers. In regards to the cooperation with PKxpert Wieslab’s VP Michael Benjamin Akoh says: “The collaboration between Wieslab AB and PKxpert AB will give many of our customers an easier and wider access to drug development services through two specialist service providers. I believe that many of our customers will find this attractive”.  

Wieslab’s bioanalytical services include:                                                    

  • Development and validation of immunoassays according to relevant guidelines
  • Expertise in various different technologies and methods (CBA, LBA, RIA, ELISA, MSD)
  • Bioanalysis of biotherapeutics and biosimilars
  • Safety and efficacy:  PK, immunogenicity and biomarker studies
  • Samples analysis in a GLP laboratory environment

For further information see homepages or please contact

PKxpert AB, Annsofi Nihlén, CEO: annsofi.nihlen@pkxpert.com

Wieslab AB, Michael Akoh, VP: Michael.akoh@eurodiagnostica.com

www.wieslab.com www.PKxpert.com


« Tillbaka